B-myb is a highly conserved member of the myb proto-oncogene family that en
codes a ubiquitously expressed 110-kDa sequence-specific DNA-binding protei
n. Transactivation of Myb-inducible promoters by B-Myb is repressed by a re
gulatory domain located at the C-terminus of the protein. Cyclin A/Cdk2-med
iated phosphorylation apparently releases the negative constraint and trigg
ers B-Myb transactivation potential. Two-dimensional tryptic phosphopeptide
analysis indicated that the majority of the sites phosphorylated bl vivo a
re targeted irt vitro by cyclin A/Cdk2. Six sites in B-Myb fulfil the requi
rements for recognition by Cdk2. Using point mutation of the phosphorylatio
n sites to nonphosphorylatable amino acids, we show that five of these site
s are targets for Cdk2 in vivo. Mutation of one of these residues (T-524) t
o alanine diminished the ability of B-Myb to promote transcription of a rep
orter gene, suggesting that phosphorylation of B-Myb at this site is import
ant for the regulation of its activity by cyclin A/Cdk2.